JPRN-UMIN000024091已完成未知
Phase II study of capecitabine and temozolomide (CAPTEM)in patients with unresectable neuroendocrien tumor - CAPTEM therapy for unresectable neuroendocrine tumor
yokohama city university hospital oncology division0 个研究点目标入组 35 人开始时间: 2016年9月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
undisclosed
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 76years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Hb < 8.0g/dl WBC <3000 Neutrocyte <1500 Plt <100000 severe liver or renal disease T-bil> 3ULN Alb <3.0g/dl AST> 5 X ULN ALT> 5 X ULN brain metastasis severe bone metastasis uncontrolable DM severe heart disease
研究者
相似试验
进行中（未招募）
1 期
Medical treatment of patients with cancer in colon or rectumPatients with refractory colorectal cancerMedDRA version: 16.1Level: HLTClassification code 10010023Term: Colorectal neoplasms malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-002327-15-DKOdense University Hospital80
已完成
2 期
Capecitabine and Temozolomide for Neuroendocrine CancersNeuroendocrine TumorsNCT00869050Columbia University41
已完成
2 期
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsGastrinomaRecurrent Islet Cell CarcinomaPancreatic Polypeptide TumorInsulinomaGlucagonomaRecurrent Pancreatic CancerSomatostatinomaStage III Pancreatic CancerStage IV Pancreatic CancerNCT01525082Shaheen Shagufta20
进行中（未招募）
2 期
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsGastrinomaIslet Cell CarcinomaRecurrent Islet Cell CarcinomaSomatostatinomaGlucagonomaPancreatic Polypeptide TumorInsulinomaNCT01824875ECOG-ACRIN Cancer Research Group144
终止
2 期
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary AdenomasRecurrent Pituitary AdenomasNCT03930771Weill Medical College of Cornell University1